Endymed EBITDA vs. Shares Owned By Insiders

ENDY Stock   302.00  11.90  4.10%   
Based on the measurements of profitability obtained from Endymed's financial statements, Endymed may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Endymed's ability to earn profits and add value for shareholders.
For Endymed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Endymed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Endymed utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Endymed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Endymed over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Endymed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Endymed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Endymed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Endymed Shares Owned By Insiders vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Endymed's current stock value. Our valuation model uses many indicators to compare Endymed value to that of its competitors to determine the firm's financial worth.
Endymed is one of the top stocks in ebitda category among its peers. It also is one of the top stocks in shares owned by insiders category among its peers . The ratio of EBITDA to Shares Owned By Insiders for Endymed is about  55,102 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Endymed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Endymed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Endymed Shares Owned By Insiders vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Endymed

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
3.2 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Endymed

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
58.11 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Endymed Shares Owned By Insiders Comparison

Endymed is currently under evaluation in shares owned by insiders category among its peers.

Endymed Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Endymed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Endymed will eventually generate negative long term returns. The profitability progress is the general direction of Endymed's change in net profit over the period of time. It can combine multiple indicators of Endymed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.

Endymed Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Endymed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Endymed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Endymed's important profitability drivers and their relationship over time.

Use Endymed in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endymed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endymed will appreciate offsetting losses from the drop in the long position's value.

Endymed Pair Trading

Endymed Pair Trading Analysis

The ability to find closely correlated positions to Endymed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Endymed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Endymed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Endymed to buy it.
The correlation of Endymed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Endymed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Endymed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Endymed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Endymed position

In addition to having Endymed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Fabricated Products Thematic Idea Now

Fabricated Products
Fabricated Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Fabricated Products theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Fabricated Products Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Endymed Stock

To fully project Endymed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Endymed at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Endymed's income statement, its balance sheet, and the statement of cash flows.
Potential Endymed investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Endymed investors may work on each financial statement separately, they are all related. The changes in Endymed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Endymed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.